from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3525c/-

LFCtreatmentdescriptionclass of inhibitor

0.428

Amikacinug/mL Amikacintranslation

0.174

Cap5-10ug/mL Capreomycintranslation

0.111

Rox10-50 ug/mL Roxithromycintranslation

-0.134

SM2-5 ug/mL Streptomycintranslation

0.095

Tet5-10 ug/mL Tetracyclinetranslation

1.933

Rif0.2-5ug/mL Rifampicintranscription

0.690

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.146

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.830

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.031

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.649

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.345

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.065

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.476

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.098

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.276

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.531

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.516

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.949

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.475

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.881

KCN5-20 ug/mL Potassium cyaniderespiration

0.157

NaN30.2-2 mM Sodium aziderespiration

-0.555

Nigericin50 uM Nigericinrespiration

1.065

TRC10-150 ug/mL Triclosanrespiration

-0.004

TRZ10-25 ug/mL Thioridazinerespiration

-1.052

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.402

menadione6-10 ug/mL Menadionerespiration

0.550

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.327

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.663

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.146

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.689

NRP_1Non-replicating persistence stage 1dosRassociated

0.028

Amp0.2mg/mL AmpicillincellWall

-0.230

Cephalexin20-100 ug/mL CephalexincellWall

0.064

Cerulenin0.32-5 ug/mL CerulenincellWall

0.928

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.100

EMB10-20 ug/mL EthambutolcellWall

0.189

Eta12-40 ug/mL EthionamidecellWall

0.541

INH0.2-0.4 ug/mL IsoniazidcellWall

1.326

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.244

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.285

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.332

BZA0.12 mg/mL BenzamidearomaticAmides

-0.076

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.594

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.238

H2O24 mM hydrogen peroxideDNAdamaging

0.011

Levo10 ug/mL LevofloxacinDNAdamaging

-0.954

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.183

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.196

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.026

UVUV-irradiationDNAdamaging

2.630

ARP41-4 ug/mL Antitubercular compound ARP4?

0.008

Antimycin12.5-50 ug/mL Antimycin A?

0.406

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.100

PA_110-50 ug/mL Antitubercular compound PA-1?

0.577

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.003

PA8240.2-2 ug/mL PA-824?

-0.744

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.339

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.457

Verapamil50 uM Verapamil?

-0.057

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.028

methoxatin10-20 ug/mL Methoxatin?